In response to cancer cells, the complement system generates the lytic membrane attack complex (MAC) on the targeted cell, working with CD8(+) T cells, mature dendritic cells, M1 macrophages, T help 1 cell, N1 neutrophils, and natural killer cells to elicit an anti-tumor immune response. The gene discussed is CD8A; the disease is cancer.